Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03453723Phase 4Completed
Phase 4, randomised, single-blind trial (2 arms), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Pain Intensity Score (Cameron Type Scale) at Day 1. Started Apr 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03453723.